Yukihiro Furusawa

Dr. Yukihiro Furusawa

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in Molecular Nutrition & Food Research
Verified
Journal Article
Open access
RIRiko Ishibashi
Riko Ishibashi
YFYukihiro Furusawa
Yukihiro Furusawa
HHHiroe Honda
Hiroe Honda
YWYasuharu Watanabe
Yasuharu Watanabe
SFShiho Fujisaka
Shiho Fujisaka
Yoshinori NagaiYoshinori Nagai
Yoshinori Nagai
Scope: Isoliquiritigenin (ILG) has been reported to attenuate adipose tissue inflammation and metabolic disorder; however, the underlying mechanisms remain to be elucidated. The aim of this study is to elucidate whether ILG shows the anti‐inflammatory and antimetabolic syndrome effects through gut microbiota modification.Methods and results: Mice are fed a high‐fat diet (HFD) with or without ILG for up to 12 weeks. The effect of ILG on body weight, blood glucose level, adipose tissue inflammation, gut barrier function, and gut microbiota composition are investigated. ILG supplementation alleviates HFD‐induced obesity, glucose tolerance, and insulin resistance and suppresses inflammatory gene expression in epididymal white adipose tissue (eWAT). Moreover, ILG supplementation modifies gut bacterial composition by increasing the abundance of antimetabolic disease‐associated species (e.g., Parabacteroides goldsteinii and Akkemansia muciniphila) and up‐regulated genes associated with gut barrier function. Fecal microbiome transplantation (FMT) from ILG‐fed donors counteract HFD‐induced body and eWAT weight changes, inflammation‐related gene expression, glucose tolerance, and insulin resistance, thereby suggesting that ILG‐responsive gut bacteria exerts anti‐inflammatory and antimetabolic syndrome effects.Conclusion: Alterations in gut bacteria underly the beneficial effects of ILG against adipose tissue inflammation and metabolic disorders. ILG may be a promising prebiotic for the prevention and treatment of metabolic syndrome.

30 March 2023 in Molecules
Verified
Journal Article
Open access
PDF file
SCSeita Chudan
Seita Chudan
RIRiko Ishibashi
Riko Ishibashi
MNMiyu Nishikawa
Miyu Nishikawa
YTYoshiaki Tabuchi
Yoshiaki Tabuchi
Yoshinori NagaiYoshinori Nagai
Yoshinori Nagai
YFYukihiro Furusawa
Yukihiro Furusawa
The health benefits of wheat-derived arabinoxylan, a commonly consumed dietary fiber, have been studied for decades. However, its effect on the gut microenvironment and inflammatory bowel disease remains unclear. The objective of this study was to understand the effect of wheat-derived arabinoxylan on gut microbiota, colonic regulatory T cells (Tregs), and experimental colitis. In this study, healthy and chronic colitis model mice were fed chow containing cellulose or wheat-derived arabinoxylan for 2–6 weeks and subjected to subsequent analysis. A 16S-based metagenomic analysis of the fecal DNA revealed that Lachnospiraceae, comprising butyrate-producing and Treg-inducing bacteria, were overrepresented in arabinoxylan-fed mice. In line with the changes in the gut microbiota, both the fecal butyrate concentration and the colonic Treg population were elevated in the arabinoxylan-fed mice. In a T cell transfer model of chronic colitis, wheat-derived arabinoxylan ameliorated body weight loss and colonic tissue inflammation, which may, in part, be mediated by Treg induction. Moreover, wheat-derived arabinoxylan suppressed TNFα production from type 1 helper T cells in this colitis model. In conclusion, wheat-derived arabinoxylans, by altering the gut microenvironment, may be a promising prebiotic for the prevention of colitis.

Verified
Journal Article
Open access
PDF file
YTYuki Tada
Yuki Tada
KKKaichi Kasai
Kaichi Kasai
NMNana Makiuchi
Nana Makiuchi
NINaoya Igarashi
Naoya Igarashi
KKKoudai Kani
Koudai Kani
Yoshinori NagaiYoshinori Nagai
Yoshinori Nagai
Macrophages play critical roles in the pathogenesis of non-alcoholic steatohepatitis (NASH). However, it is unclear which macrophage subsets are critically involved in the development of inflammation and fibrosis in NASH. In TSNO mice fed a high-fat/cholesterol/cholate-based diet, which exhibit advanced liver fibrosis that mimics human NASH, we found that Kupffer cells (KCs) were less abundant and recruited macrophages were more abundant, forming hepatic crown-like structures (hCLS) in the liver. The recruited macrophages comprised two subsets: CD11c+/Ly6C− and CD11c−/Ly6C+ cells. CD11c+ cells were present in a mesh-like pattern around the lipid droplets, constituting the hCLS. In addition, CD11c+ cells colocalized with collagen fibers, suggesting that this subset of recruited macrophages might promote advanced liver fibrosis. In contrast, Ly6C+ cells were present in doughnut-like inflammatory lesions, with a lipid droplet in the center. Finally, RNA sequence analysis indicates that CD11c+/Ly6C− cells promote liver fibrosis and hepatic stellate cell (HSC) activation, whereas CD11c−/Ly6C+ cells are a macrophage subset that play an anti-inflammatory role and promote tissue repair in NASH. Taken together, our data revealed changes in liver macrophage subsets during the development of NASH and shed light on the roles of the recruited macrophages in the pathogenesis of advanced fibrosis in NASH.

1 December 2009 in Cell Biology International
Verified
Journal Article
Closed access
PDF file
YFYukihiro Furusawa
Yukihiro Furusawa
YTYoshiaki Tabuchi
Yoshiaki Tabuchi
ITIchiro Takasaki
Ichiro Takasaki
SWShigehito Wada
Shigehito Wada
KOKenzo Ohtsuka
Kenzo Ohtsuka
TKTakashi Kondo
Takashi Kondo

9 February 2023 in Food & Function
Verified
Journal Article
Closed access
PDF file
SCSeita Chudan
Seita Chudan
RIRiko Ishibashi
Riko Ishibashi
MNMiyu Nishikawa
Miyu Nishikawa
YTYoshiaki Tabuchi
Yoshiaki Tabuchi
YNYoshinori Nagai
Yoshinori Nagai
YFYukihiro Furusawa
Yukihiro Furusawa
Soluble oat fiber increased colonic butyrate, peripherally-induced Treg cells and thus alleviated TNBS-induced colitis, which coincided with overrepresentation of F. rodentium (a human analog of H. biformis) possessing butyrate-producing metagenomes.

12 February 2014 in Nature
Verified
Journal Article
Open access
PDF file
YFYukihiro Furusawa
Yukihiro Furusawa
YOYuuki Obata
Yuuki Obata
SFShinji Fukuda
Shinji Fukuda
TETakaho A. Endo
Takaho A. Endo
GNGaku Nakato
Gaku Nakato
HOHiroshi Ohno
Hiroshi Ohno
Erratum: Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells